Heparan sulphate proteoglycan expression in human primary liver tumours

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 290-297

  Roskams, Tania ^a   De Vos, Rita ^a   David, Guido ^a   Van Damme, Boudewijn ^a   Desmet, Valeer ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cholangiocarcinoma; Glypican; Heparan sulphate proteoglycans; Hepatocellular carcinoma; Liver; Perlecan; Syndecan

Indexed keywords

GLYPICAN; HEPARAN SULFATE; PERLECAN; PROTEOHEPARAN SULFATE; SYNDECAN;

ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR VASCULARIZATION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, IMMUNOELECTRON; PROTEOGLYCANS; RETROSPECTIVE STUDIES; SYNDECAN-1; SYNDECANS;

EID: 0031851412     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<290::AID-PATH91>3.0.CO;2-I     Document Type: Article

References (35)

1. David G. Integral membrane heparan sulfate proteoglycans. Faseb J 1993; 7: 1023-1030.
2. Roskams T, Moshage H, De Vos R, David G, Yap P, Desmet V. Integral membrane and matrix heparan sulfate proteoglycan expression in normal human liver. Hepatology 1995; 21: 950-958.
3. Roskams T, De Vos R, Rosenbaum J, David G, Desmet V. Integral membrane and matrix heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases. Hepatology 1996; 24: 524-532.
4. Gallai M, Kovalsky I, Knittel T, Neubauer K, Armbrust T, Ramadori G. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells. Am J Pathol 1996; 148: 1463-1471.
5. Weiner O, Zoremba M, Gressner A. Gene expression of syndecans and betaglycan in isolated rat liver cells. Cell Tissue Res 1996; 285: 11-16.
6. Ishak K, Anthony P, Sobin L. Histological typing of tumours of the liver. In: World Health Organization International Histological Classification of Tumours. 2nd edn. Berlin: Springer-Verlag; 1994.
7. Lories V, Cassiman JJ, Van den Berghe H, David G. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem 1992; 267: 1116-1122.
8. Lories V, Cassiman JJ, Van den Berghe H, David G. Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblasts. J Biol Chem 1989; 264: 7009-7016.
9. David G, van der Schueren B, Marynen P, Cassiman JJ, van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118: 961-969.
10. David G, Lories V, Decock B, Marynen P, Cassiman JJ, Van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 1990; 111: 3165-3176.
11. Heremans A, van der Schueren B, de Cock B, et al. Matrix-associated heparan sulfate proteoglycan: core protein-specific monoclonal antibodies decorate the pericellular matrix of connective tissue cells and the stromal side of basement membranes. J Cell Biol 1989; 109: 3199-3211.
12. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992; 119: 961-975.
13. Wijdenes J, Vooijs W, Clement C, et al. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 1996; 94: 318-323.
14. De Vos R, De Wolf-Peeters C, van den Oord JJ, Desmet V. A recommended procedure for ultrastructural immunohistochemistry on small human tissue samples. J Histochem Cytochem 1985; 33: 959-964.
15. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 1995; 83: 357-360.
16. Flaumenhaft R, Rifkin DB. The extracellular regulation of growth factor action. Mol Biol Cell 1992; 3: 1057-1065.
17. Rescan P, Clément B, Yamada Y, et al. Differential expression of laminin chains and receptor (LPB-32) in fetal and neoplastic hepatocytes compared to normal adult hepatocytes in vivo and in culture. Am J Pathol 1990; 137: 701-709.
18. Lyon M, Deakin J, Gallagher J. Liver heparan sulfate structure. J Biol Chem 1994; 269: 11208-11215.
19. Pierce A, Lyon M, Hampson IN, Cowling GJ, Gallagher JT. Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver. J Biol Chem 1992; 267: 3894-3900.
20. Lyon M, Gallagher JT. Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver. Biochem J 1991; 273: 415-422.
21. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem 1994; 269: 11216-11223.
22. Schwall R, Chang L, Godowski P, et al. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J Cell Biol 1996; 133: 709-718.
23. Sakata H, Stahl S, Taylor W, et al. Heparin binding and oligomerization of hepatocyte growth factor scatter factor isoforms - heparan sulfate glycosaminoglycan requirement for Met binding and signalling. J Biol Chem 1997; 272: 9457-9463.
24. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-848.
25. Lemmon M, Schlessinger J. Regulation of signal diversity by receptor oligomerization. Trends Biochem Sci 1994; 19: 459-463.
26. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB. Role of extracellular matrix in the action of basic fibroblast growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Phys 1989; 140: 75-81.
27. Raines EW, Ross R. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J Cell Biol 1992; 116: 533-543.
28. Masumoto A, Yamamoto N. Stimulation of DNA synthesis in hepatocytes by hepatocyte growth factor bound to extracellular matrix. Biochem Biophys Res Commun 1993; 191: 1218-1223.
29. Clement B, Segui-Real B, Hassell JR, Martin GR, Yamada Y. Identification of a cell surface-binding protein for the core protein of the basement membrane proteoglycan. J Biol Chem 1989; 264: 12467-12471.
30. Burgess WH, Shaheen AM, Hampton B, Donohue PJ, Winkles JA. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis. J Cell Biochem 1991; 45: 131-138.
31. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 1992; 267: 22156-22162.
32. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. Faseb J 1990; 4: 176-187.
33. Wiedlocha A, Falnes P, Madshus I, Sandvig K, Olsnes S. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 1994, 76: 1039-1051.
34. Ishihara M, Fedarko NS, Conrad HE. Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. J Biol Chem 1987; 262: 4708-4716.
35. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79: 1005-1013.